Patsoukis, Nikolaos
Boussiotis, Vassiliki A. http://orcid.org/0000-0002-3963-1518
Article History
First Online: 27 October 2022
Competing interests
: V.A.B. has patents on the PD-1 pathway licensed by Bristol-Myers Squibb, Roche, Merck, EMD-Serono, Boehringer Ingelheim, AstraZeneca, Novartis and Dako. The authors declare no other competing interests.